Solid Tumors Harboring a BRAF V600 Mutation
1 clinical trials · Condition
◉ Watch Solid Tumors Harboring a BRAF V600 Mutation
| Record | Firm | Date |
|---|---|---|
| A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors (NCT01543698) | Pfizer | 2012-05-28 |
Track Solid Tumors Harboring a BRAF V600 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.